The structure of H-2Kb and Kbm8 complexed to a herpes simplex virus determinant: Evidence for a conformational switch that governs T cell repertoire selection and viral resistance

Journal of Immunology

Volumn 173, Issue 1, 2004, Pages 402-409

  Webb, Andrew I ^a   Borg, Natalie A ^a   Dunstone, Michelle A ^a   Kjer Nielsen, Lars ^b   Beddoe, Travis ^a   McCluskey, James ^b,c   Carbone, Francis R ^b,c   Bottomley, Stephen P ^a   Aguilar, Marie Isabel ^a   Purcell, Anthony W ^b,c   Rossjohn, Jamie ^a  

^a MONASH UNIVERSITY   (Australia)

^b Dept of Microbiology and Immunology ^*  (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIGEN; ARGININE; CD8 ANTIGEN; GLYCOPROTEIN B; H2 ANTIGEN; H2K ANTIGEN; K ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR CDR1ALPHA; T LYMPHOCYTE RECEPTOR VALPHA; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; CELL SELECTION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DYNAMICS; GENETIC POLYMORPHISM; HERPES SIMPLEX VIRUS; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS RESISTANCE;

EID: 2942754097     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.1.402     Document Type: Article

References (39)

1. Little, A. M., and P. Parham. 1999. Polymorphism and evolution of HLA class I and II genes and molecules. Rev. Immunogenet. 1:105.
2. Macdonald, W. A., A. W. Purcell, N. Mifsud, L. K. Ely, D. S. Williams, L. Chang, J. J. Gorman, C. S. Clements, L. Kjer-Nielsen, D. M. Koelle, et al. 2003. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire and T cell recognition. J. Exp. Med. 198:679.
3. Hildebrand, W. H., H. R. Turnquist, K. R. Prilliman, H. D. Hickman, E. L. Schenk, M. M. McIlhaney, and J. C. Solheim. 2002. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Hum. Immunol. 63:248.
4. Neisig, A., R. Wubbolts, X. Zang, C. Melief, and J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196.
5. Wallace, M. E., R. Keating, W. R. Heath, and F. R. Carbone. 1999. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73:7619.
6. 3 loop docking governs the cross-recognition of closely related peptide:class I complexes. J. Immunol. 167:836.
7. Nathenson, S. G., J. Geliebter, G. M. Pfaffenbach, and R. A. Zeff. 1986. Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications. Annu. Rev. Immunol. 4:471.
8. bm8 reveal that subtle changes in the peptide environment impact thermostability and alloreactivity. Immunity 14:231.
9. Hillig, R. C., M. Huelsmeyer, W. Saenger, K. Welfle, R. Misselwitz, H. Welfle, C. Kozerski, A. Volz, B. Uchanska-Ziegler, and A. Ziegler. 2004. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 279:652.
10. Hulsmeyer, M., R. C. Hillig, A. Volz, M. Ruhl, W. Schroder, W. Saenger, A. Ziegler, and B. Uchanska-Ziegler. 2002. HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J. Biol. Chem. 277:47844.
11. 116, differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition. Eur. J. Immunol. 28:2508.
12. Fiorillo, M. T., L. Meadows, M. D'Amato, J. Shabanowitz, D. F. Hunt, E. Appella, and R. Sorrentino. 1997. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 27:368.
13. Garcia-Peydro, M., M. Marti, and J. Lopez de Castro. 1999. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis. J. Immunol. 163:2299.
14. b-restricted ovalbumin determinant. Eur. J. Immunol. 20:2431.
15. Stefanski, H. E., S. C. Jameson, and K. A. Hogquist. 2000. Positive selection is limited by available peptide-dependent MHC conformations. J. Immunol. 164:3519.
16. de Waal, L. P., W. M. Kast, R. W. Melvold, and C. J. Melief. 1983. Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants. J. Immunol. 130:1090.
17. Clark, S. S., and J. Forman. 1983. Structure function relationship of class I MHC molecules. Surv. Immunol. Res. 2:203.
18. Messaoudi, I., J. A. Guevara Patino, R. Dyall, J. LeMaoult, and J. Nikolich-Zugich. 2002. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298:1797.
19. Macdonald, W., D. S. Williams, C. S. Clements, J. J. Gorman, L. Kjer-Nielsen, A. G. Brooks, J. McCluskey, J. Rossjohn, and A. W. Purcell. 2002. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex. FEBS Lett. 527:27.
20. Kundrot, C. E. 2004. Which strategy for a protein crystallization project? Cell. Mol. Life Sci. 61:525.
21. Weber, P. C. 1997. Overview of protein crystallization methods. Methods Enzymol. 276(Pt. A):13.
22. Reiser, J. B., C. Gregoire, C. Darnault, T. Mosser, A. Guimezanes, A. M. Schmitt-Verhulst, J. C., Fontecilla-Camps, G. Mazza, B. Malissen, and D. Housset. 2002. A T cell receptor CDR3β loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16:345.
23. Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, et al. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54(Pt. 5):905.
24. Jones, T. A., J. Y. Zou, S. W. Cowan, and Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47(Pt. 2):110.
25. Webb, A. I., M. A. Dunstone, W. Chen, M.-I. Aguilar, Q. Chen, H. Jackson, L. Chang, L. Kjer-Nielsen, T. Beddoe, J. McCluskey, et al. 2004. Functional and structural characteristics of NY-ESO-1 related HLA-A2 restricted epitopes and the design of a novel immunogenic analogue. J. Biol. Chem. 279:23438.
26. Rognan, D., L. Scapozza, G. Folkers, and A. Daser. 1995. Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen. Proc. Natl. Acad. Sci. USA 92:753.
27. 2-microglobulin mutants with MHC class I heavy chains and structural analysis demonstrate allele-specific inreractions. Mol. Immunol. 36:561.
28. Brunger, A. T., P. D. Adams, and L. M. Rice. 1997. New applications of simulated annealing in X-ray crystallography and solution NMR. Structure 5:325.
29. Huard, R., R. Dyall, and J. Nikolic-Zugic. 1997. The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding. Int. Immunol. 9:1701.
30. Kjer-Nielsen, L., C. S. Clements, A. G. Brooks, A. W. Purcell, M. R. Fontes, J. McCluskey, and J. Rossjohn. 2002. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J. Immunol. 169:5153.
31. Reid, S. W., S. McAdam, K. J. Smith, P. Klenerman, C. A. O'Callaghan, K. Harlos, B. K. Jakobsen, A. J. McMichael, J. I. Bell, D. I. Stuart, and E. Y. Jones. 1996. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J. Exp. Med. 184:2279.
32. Reiser, J. B., C. Darnault, C. Gregoire, T. Mosser, G. Mazza, A. Kearney, P. A. van der Merwe, J. C. Fontecilla-Camps, D. Housset, and B. Malissen. 2003. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4:241.
33. Kjer-Nielsen, L., C. S. Clements, A. W. Purcell, A. G. Brooks, J. C. Whisstock, S. R. Burrows, J. McCluskey, and J. Rossjohn. 2003. A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity. Immunity 18:53.
34. Boniface, J. J., Z. Reich, D. S. Lyons, and M. M. Davis. 1999. Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc. Natl. Acad. Sci. USA 96:11446.
35. Willcox, B. E., G. F. Gao, J. R. Wyer, J. E. Ladbury, J. I. Bell, B. K. Jakobsen, and P. A. van der Merwe. 1999. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10:357.
36. Krogsgaard, M., N. Prado, E. J. Adams, X. L. He, D. C. Chow, D. B. Wilson, K. C. Garcia, and M. M. Davis. 2003. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell. 12:1367.
37. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβT cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209.
38. Zernich, D., A. W. Purcell, W. A. Macdonald, L. Kjer-Nielsen, L. K. Ely, N. Laham, T. L. Crockford, N. A. Mifsud, M. Bharadwaj, L. Chang, et al. 2004. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J. Exp. Med. In press.
39. Lefranc, M.-P. 2003. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 31:307.